TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT07759817: Safety and Efficacy of a 2,910 nm Fractional Ablative Fiber Laser (UltraClear®) for Improvements of Skin Laxity and Lifting of the Lower Face, Submental, and Neck Treatment Areas

Sponsor: FA Corporation · Phase: PHASE2 · Area: DERMATOLOGY_AESTHETIC · Target Enrollment: 50 pts

Competing Trials Overlap

4 Active Trials

Excess Burn Exposure

$4,360,200

Rescue Site Savings

+$2,889,600

Unlock Full NCT07759817 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT07759817 Rescue Dossier →